What are the key financial results for Johnson & Johnson in this quarter?

The provided text is a directory listing from the SEC's EDGAR system and does not contain the specific financial statements, revenue figures, profit margins, or segment performance details necessary to answer this question. A full review of the actual 10-Q document would be required.

What is the significance of this 10-Q filing for investors?

This filing signifies Johnson & Johnson's adherence to regulatory requirements for quarterly financial reporting. It demonstrates the company's commitment to transparency by providing regular updates on its financial status to investors and the public. While the specific financial data is not in the provided text, the act of filing is a positive indicator of corporate governance.

Where can I find the detailed financial information from this report?

The provided text is only a directory listing and does not contain the financial statements. To access the detailed financial information, you would need to retrieve the actual 10-Q filing document (likely a .txt file) from the SEC's EDGAR database or through Johnson & Johnson's investor relations website.

What does the filing date of August 10, 1995, tell me about the company?

The filing date indicates that Johnson & Johnson submitted its quarterly report to the SEC on time, shortly after the period ending July 1, 1995, concluded. This suggests efficient internal processes for financial reporting and compliance, which is generally viewed positively by investors.

JNJ 10-Q Quarterly Report Q3 FY1995 — Revenue, Net Income, EPS

Summary

Johnson & Johnson's (JNJ) 10-Q filing for the period ending July 1, 1995, reveals the company's financial performance during the second quarter of that fiscal year. While specific financial figures are not detailed in the provided text, the filing serves as an official update on the company's operational status and financial health. Investors should note that this report provides insights into the company's adherence to reporting standards and its ongoing disclosures to the public. This filing is crucial for understanding JNJ's commitment to transparency and regulatory compliance. While the limited text doesn't allow for a deep dive into revenue, profit, or specific segment performance, it signifies that the company is actively communicating its financial standing to stakeholders, which is a positive indicator for investor confidence.

Key Highlights

1The filing is a 10-Q Quarterly Report for Johnson & Johnson (JNJ).
2The reporting period concluded on July 1, 1995.
3The report was filed on August 10, 1995, indicating timely disclosure.
4The provided text is a directory listing from the SEC EDGAR system, not the full financial report content.
5This filing demonstrates Johnson & Johnson's commitment to regular financial disclosure to investors and the public.
6Investors can infer that the company is operating under standard financial reporting practices as required by the SEC.

JOHNSON & JOHNSON Quarterly Report for Q3 Ended Jul 2, 1995

Summary

Key Highlights

Frequently Asked Questions